These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Identification of a 160-kD molecule as a component of the basement membrane zone and as a minor bullous pemphigoid antigen. Zhu XJ, Niimi Y, Bystryn JC. J Invest Dermatol; 1990 Jun; 94(6):817-21. PubMed ID: 1693941 [Abstract] [Full Text] [Related]
6. Studies of the relationship of the 230-kD and 180-kD bullous pemphigoid antigens. Robledo MA, Kim SC, Korman NJ, Stanley JR, Labib RS, Futamura S, Anhalt GJ. J Invest Dermatol; 1990 Jun; 94(6):793-7. PubMed ID: 2192002 [Abstract] [Full Text] [Related]
7. Comparative expression of bullous pemphigoid antigens in normal human epidermis and cultured keratinocytes. Su H, Reano A, Viac J, Thivolet J. Clin Immunol Immunopathol; 1989 Jun; 51(3):406-13. PubMed ID: 2656012 [Abstract] [Full Text] [Related]
8. Difference in binding sites of autoantibodies against 230- and 170-kD bullous pemphigoid antigens on salt-split skin. Onodera Y, Shimizu H, Hashimoto T, Ishiko A, Ebihara T, Tanaka M, Nishikawa T. J Invest Dermatol; 1994 May; 102(5):686-90. PubMed ID: 8176249 [Abstract] [Full Text] [Related]
9. Bullous pemphigoid sera that contain antibodies to BPAg2 also contain antibodies to LABD97 that recognize epitopes distal to the NC16A domain. Egan CA, Taylor TB, Meyer LJ, Petersen MJ, Zone JJ. J Invest Dermatol; 1999 Feb; 112(2):148-52. PubMed ID: 9989788 [Abstract] [Full Text] [Related]
10. [Use of the immunoblotting technic for the study of antibodies present in the serum of patients with bullous pemphigoid]. Reano A, Thivolet J, Staquet MJ, Fargier MC. Ann Dermatol Venereol; 1988 Feb; 115(1):11-8. PubMed ID: 2453132 [Abstract] [Full Text] [Related]
11. Characterization of bullous pemphigoid antibodies by use of recombinant bullous pemphigoid antigen proteins. Tanaka M, Hashimoto T, Amagai M, Shimizu N, Ikeguchi N, Tsubata T, Hasegawa A, Miki K, Nishikawa T. J Invest Dermatol; 1991 Oct; 97(4):725-8. PubMed ID: 1940445 [Abstract] [Full Text] [Related]
12. Assessment of skin basement membrane zone antibodies in the urine of patients with acquired subepidermal immunobullous diseases. Allen J, Shears E, Powell J, Wojnarowska F. Br J Dermatol; 2001 Mar; 144(3):540-5. PubMed ID: 11260011 [Abstract] [Full Text] [Related]
13. Canine bullous pemphigoid (BP): identification of the 180-kd canine BP antigen by circulating autoantibodies. Iwasaki T, Olivry T, Lapiere JC, Chan LS, Peavey C, Liu YY, Jones JC, Ihrke PJ, Woodley DT. Vet Pathol; 1995 Jul; 32(4):387-93. PubMed ID: 7483213 [Abstract] [Full Text] [Related]
14. Western blot analysis of the antigen in pemphigoid gestationis. Kelly SE, Bhogal BS, Wojnarowska F, Whitehead P, Leigh IM, Black MM. Br J Dermatol; 1990 Apr; 122(4):445-9. PubMed ID: 2186774 [Abstract] [Full Text] [Related]
15. Cicatricial pemphigoid antigen differs from bullous pemphigoid antigen by its exclusive extracellular localization: a study by indirect immunoelectronmicroscopy. Bédane C, Prost C, Bernard P, Catanzano G, Bonnetblanc JM, Dubertret L. J Invest Dermatol; 1991 Jul; 97(1):3-9. PubMed ID: 2056190 [Abstract] [Full Text] [Related]
16. Linear IgA bullous dermatosis with IgA antibodies exclusively directed against the 180- or 230-kDa epidermal antigens. Ghohestani RF, Nicolas JF, Kanitakis J, Claudy A. J Invest Dermatol; 1997 Jun; 108(6):854-8. PubMed ID: 9182810 [Abstract] [Full Text] [Related]
17. A novel bullous pemphigoid antigen (BP125) located in the deeper layers of the basement membrane zone. Gao SQ, Bystryn JC. Arch Dermatol; 1994 Jul; 130(7):873-8. PubMed ID: 8024275 [Abstract] [Full Text] [Related]
19. Bullous pemphigoid sera react specifically with various domains of BP230, most frequently with C-terminal domain, by immunoblot analyses using bacterial recombinant proteins covering the entire molecule. Hamada T, Nagata Y, Tomita M, Salmhofer W, Hashimoto T. Exp Dermatol; 2001 Aug; 10(4):256-63. PubMed ID: 11493314 [Abstract] [Full Text] [Related]